Merion

Merion EV/EBIT

The EV/EBIT (Enterprise Value to EBIT) of Merion (EWLU) as of Oct 30, 2026 is -0.01. In the previous year, EV/EBIT (Enterprise Value to EBIT) was -0.01 — a change of 68.09% (lower).

EV/EBIT

-0.01

YoY

68.09%

Last updated:

EV/EBIT (Enterprise Value to EBIT) of Merion is 2021 -0.01 . EV/EBIT (Enterprise Value to EBIT) of Merion was 2020 -0.01 . It decreases by 68.09% lower compared to the previous year.

The Merion EV/EBIT history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EV/EBIT
Date
EV/EBIT
Jan 1, 2014
0.00 USD
Jan 1, 2015
-0.00 USD
Jan 1, 2016
-0.01 USD
Jan 1, 2017
-0.01 USD
Jan 1, 2018
-0.00 USD
Jan 1, 2019
-0.01 USD
Jan 1, 2020
-0.01 USD
Jan 1, 2021
-0.01 USD
The Merion EV/EBIT history
YEAREV/EBITYoY
-0.01+68.09%
-0.01-50.08%
-0.01+159.52%
-0.00-69.87%
-0.01-5.23%
-0.01+371.70%
-0.00-187.91%
0.00—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Merion Valuation

Details

Historical Valuation Multiples

ⓘ

Price-to-Earnings Ratio (P/E)

The P/E ratio divides Merion's share price by its earnings per share. It tells you how many years of current earnings you are "paying for" when you buy the stock. A P/E of 20 means you pay $20 for every $1 of annual earnings. The S&P 500 historically trades at an average P/E of roughly 15–17. A P/E significantly above that may signal high growth expectations; one below may indicate undervaluation — or declining business quality.

Price-to-Sales Ratio (P/S)

The P/S ratio divides market capitalization by total revenue. Unlike the P/E ratio, it works even for companies that are not yet profitable, making it essential for evaluating high-growth firms. A P/S below 1.0 may indicate undervaluation, while ratios above 10 are typically reserved for fast-growing tech or SaaS companies with high expected future margins.

Price-to-EBIT Ratio

This ratio relates Merion's market price to its operating earnings, excluding the effects of debt structure and tax jurisdiction. It is particularly useful for comparing companies across different countries or with different levels of leverage, because it focuses purely on operational profitability. Lower values suggest cheaper operational earnings.

How to Use This Chart

This chart plots Merion's valuation multiples over time. Compare the current P/E, P/S, and P/EBIT to their own historical averages — if the current ratio is well below the multi-year average, the stock may be relatively cheap compared to its own track record. Combine this with industry comparisons: a P/E that looks high in absolute terms may be justified if Merion grows earnings faster than its peers.

Merion Stock analysis

What does Merion do? Merion, Inc. generates revenue by selling its own line of seven nutritional supplements and seven skin-care products through its website dailynu.com. The company's nutritional supplements, including Dibeier Granules & Oral, Longevity, US-Liver Gold, Cell Power, OPC Spa, Heart Power, and O2 Cell Power, are formulated using a micro molecular nutrition process. Its skin-care products, such as anti-aging cream, facial cream, facial serum, body lotion, sun protection, facial toner, and facial cleanser, focus on restoring epidermal calcium. The firm also sells third-party health and nutrition products that are already available through other vendors. The company's primary customers are individuals seeking health and nutritional supplements and personal care products, purchasing directly through dailynu.com. Merion does not manufacture its own skin-care products but distributes third-party brands that are already sold by other vendors. The firm's revenue streams include direct sales of its proprietary supplement line and the third-party products it resells. Merion's business model relies on e-commerce sales via its website, with no physical retail presence. The company's product portfolio is divided into two main segments: its own micro molecular nutrition supplements and third-party health and nutrition products. The skin-care segment focuses on products that restore epidermal calcium, while the nutritional segment features seven proprietary supplements made using its unique formula. Merion is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Merion stock

EV/EBIT (Enterprise Value to EBIT) of Merion is -0.01 in 2021.

EV/EBIT (Enterprise Value to EBIT) of Merion changed from -0.01 to -0.01, representing a 68.09% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EV/EBIT (Enterprise Value to EBIT) Merion since 2006 – with annual values, charts, and detailed analysis.

The EV/EBIT ratio measures a company's enterprise value relative to its operating earnings. It accounts for debt, making it useful for comparing companies with different capital structures.

EV/EBIT = Enterprise Value / Earnings Before Interest and Taxes

To evaluate EV/EBIT (Enterprise Value to EBIT)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EV/EBIT (Enterprise Value to EBIT).

A 'good' varies by industry and company stage. On Eulerpool, you can compare EV/EBIT (Enterprise Value to EBIT)'s Merion with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Merion

All Key Metrics — Merion